Drugs / Dipeptiven
Dipeptiven
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT04560309 | Jan → Oct 2021 | coronary artery disorder | National Cardiovascular Center Harapan Kita Hospital Indonesia | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT02130674 | Jan 2005 → Feb 2011 | traumatic brain injury | University of Zurich | Completed | No outcome recorded |
| Phase 4 | NCT00732849 | Jun → Sep 2002 | — | Jagiellonian University | Completed | No outcome recorded |
| Phase 4 | NCT00558155 | Jun 2001 → Dec 2005 | gastric cancer, malignant pancreatic neoplasm | Jagiellonian University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05140772 Comparator | Jun 2020 → Dec 2021 | — | Menoufia University | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00647036 Comparator | Jul 2009 → Dec 2011 | — | Institute of Child Health | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05822518 Comparator | Jun 2022 → Nov 2023 | urinary bladder cancer | Menoufia University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dipeptiven | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00732849 ↗ |
| Known as | alanyl-glutamine dipeptide | “Patients suffering from severe traumatic brain injury and requiring multimodal neuromonitoring during pharmacological coma will receive alanyl-glutamine dipeptide (Dipeptiven)...” NCT02130674 ↗ |
| Known as | L-alanyl-L-glutamine dipeptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04560309 ↗ |
| Modality | Peptide | “Patients suffering from severe traumatic brain injury and requiring multimodal neuromonitoring during pharmacological coma will receive alanyl-glutamine dipeptide (Dipeptiven)...” NCT02130674 ↗ |
| Route | Intravenous | “Intravenous infusion of 0.5 mg/kgbw L-alanyl-L-glutamine dipeptide” NCT04560309 ↗ |